BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. ✅
Go to Publication ✅
The Journal of nutrition (J Nutr ) Vol: 144 Issue 11 Pages: 1787-96 Pub: 2014 Nov Epub: 2014 Sep 3 Authors Ferrario C , Taverniti V , Milani C , Fiore W , Laureati M , De Noni I , Stuknyte M , Chouaia B , Riso P , Guglielmetti S , |
|
|
Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. ✅
Go to Publication ✅
The Journal of nutrition (J Nutr ) Vol: 144 Issue 11 Pages: 1787-96 Pub: 2014 Nov Epub: 2014 Sep 3 Authors Ferrario C , Taverniti V , Milani C , Fiore W , Laureati M , De Noni I , Stuknyte M , Chouaia B , Riso P , Guglielmetti S , |
|
|
Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. ✅
Go to Publication ✅
The Journal of nutrition (J Nutr ) Vol: 144 Issue 11 Pages: 1787-96 Pub: 2014 Nov Epub: 2014 Sep 3 Authors Ferrario C , Taverniti V , Milani C , Fiore W , Laureati M , De Noni I , Stuknyte M , Chouaia B , Riso P , Guglielmetti S , |
|
|
Beneficial effects of the commercial lactic acid bacteria product, Vigiis 101, on gastric mucosa and intestinal bacterial flora in rats. ✅
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: Issue Pages: Pub: 2018 Jun 23 Epub: 2018 Jun 23 Authors Kao L , Liu TH , Tsai TY , Pan TM , |
|
|
Beneficial effects of the commercial lactic acid bacteria product, Vigiis 101, on gastric mucosa and intestinal bacterial flora in rats. ✅
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: Issue Pages: Pub: 2018 Jun 23 Epub: 2018 Jun 23 Authors Kao L , Liu TH , Tsai TY , Pan TM , |
|
|
<i>Lactobacillus paracasei</i> subsp. <i>paracasei</i> NTU 101 lyophilized powder improves loperamide-induced constipation in rats. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 6 Issue 4 Pages: e03804 Pub: 2020 Apr Epub: 2020 Apr 21 Authors Chen CL , Chao SH , Pan TM , |
|
|
<i>Lactobacillus paracasei</i> subsp. <i>paracasei</i> NTU 101 lyophilized powder improves loperamide-induced constipation in rats. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 6 Issue 4 Pages: e03804 Pub: 2020 Apr Epub: 2020 Apr 21 Authors Chen CL , Chao SH , Pan TM , |
|
|
Plant-Derived Lactobacillus paracasei IJH-SONE68 Improves the Gut Microbiota Associated with Hepatic Disorders: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 21 Pages: Pub: 2022 Oct 26 Epub: 2022 Oct 26 Authors Danshiitsoodol N , Noda M , Kanno K , Uchida T , Sugiyama M , |
|
|
In vitro Intervention of Lactobacillus paracasei N1115 Can Alter Fecal Microbiota and Their SCFAs Metabolism of Pregnant Women with Constipation and Diarrhea. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 79 Issue 7 Pages: 212 Pub: 2022 Jun 7 Epub: 2022 Jun 7 Authors Dang C , Zhao K , Xun Y , Feng L , Zhang D , Cui L , Cui Y , Jia X , Wang S , |
|
|
In vitro Intervention of Lactobacillus paracasei N1115 Can Alter Fecal Microbiota and Their SCFAs Metabolism of Pregnant Women with Constipation and Diarrhea. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 79 Issue 7 Pages: 212 Pub: 2022 Jun 7 Epub: 2022 Jun 7 Authors Dang C , Zhao K , Xun Y , Feng L , Zhang D , Cui L , Cui Y , Jia X , Wang S , |
|
|
Influence of Diet on the Effect of the Probiotic Lactobacillus paracasei in Rats Suffering From Allergic Asthma. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 737622 Pub: 2021 Epub: 2021 Sep 27 Authors Xie A , Song J , Lu S , Liu Y , Tang L , Wen S , |
|
|
Intestinal toxicity alleviation and efficacy potentiation through therapeutic administration of Lactobacillus paracasei GY-1 in the treatment of gout flares with colchicine. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 3 Pages: 1671-1688 Pub: 2024 Feb 5 Epub: 2024 Feb 5 Authors Zeng J , Li Y , Zou Y , Yang Y , Yang T , Zhou Y , |
|
|
Lactobacillus paracasei Relieves Constipation by Acting on the Acetic Acid-5-HT-Intestinal Motility Pathway. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 22 Pages: Pub: 2023 Nov 20 Epub: 2023 Nov 20 Authors Wang L , Yang S , Mei C , Tang N , Wang J , Yu Q , Wang G , Wu G , Zhao J , Chen W , |
|
|
Lactobacillus paracasei Relieves Constipation by Acting on the Acetic Acid-5-HT-Intestinal Motility Pathway. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 22 Pages: Pub: 2023 Nov 20 Epub: 2023 Nov 20 Authors Wang L , Yang S , Mei C , Tang N , Wang J , Yu Q , Wang G , Wu G , Zhao J , Chen W , |
|
|
Survival and Impact on Microbial Diversity of Lacticaseibacillus paracasei DG in a Simulation of Human Intestinal Microbial Ecosystem. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 18 Pages: Pub: 2025 Sep 13 Epub: 2025 Sep 13 Authors Duysburgh C , Fiore W , Marzorati M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
